---
title: InfinixBio vs Protheragen
slug_a: infinixbio
slug_b: obesityscientific
site: cro
review_signal_gate: closed
canonical_path: /compare/infinixbio/obesityscientific
---

# InfinixBio vs Protheragen

Side-by-side profile data from each company listing on this directory.

## InfinixBio

- Profile: [/companies/infinixbio](/companies/infinixbio)

InfinixBio — Columbus, Ohio-based contract research organization offering assay development, GLP-compliant preclinical studies including PK and immunogenicity testing, and Phase 1 and 2 clinical testing support for biotech and pharma sponsors.

Services: 11. Modalities: 1. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (11).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vivo Studies
- In Vivo PK / PD Studies
- Specialized & Large-Animal Models
- Bioanalysis
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials

### Modalities

- Gene Therapy

### Indications

- Data not yet provided.

### Phases

- Discovery
- Preclinical (IND-Enabling)
- Phase I
- Phase II

### Sourcing models

- Full-Service Outsourcing (FSO)

## Protheragen

- Profile: [/companies/obesityscientific](/companies/obesityscientific)

Protheragen — Specialized preclinical CRO dedicated to obesity research, offering comprehensive animal models, pharmacokinetic/pharmacodynamic studies, bioanalysis, and safety assessment for anti-obesity drug development.

Services: 27. Modalities: 5. Indications: 1. Locations: 0. Certifications: 0. The strongest documented coverage currently appears in services (27).

### Services

- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- Safety Pharmacology
- Preclinical In Vivo Studies
- In Vivo Efficacy Models
- In Vivo PK / PD Studies
- GLP Toxicology
- Specialized & Large-Animal Models
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Clinical Trial Services
- Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Pharmacovigilance & Drug Safety
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Cell Therapy
- Gene Therapy
- Peptide

### Indications

- Metabolic

### Phases

- Preclinical (General)
- Phase I
- Discovery
- Phase II
- Phase III
- Phase IV

### Sourcing models

- Full-Service Outsourcing (FSO)